Hemostasis Today

June, 2026
June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Ekrem Unal: Navigating the Budget Impact of Next-Generation Hemophilia Therapies in Turkey
Jun 17, 2026, 04:31

Ekrem Unal: Navigating the Budget Impact of Next-Generation Hemophilia Therapies in Turkey

Ekrem Unal, Professor of Pediatric Hematology Oncology and Pediatric HSCT at Hasan Kalyoncu University, Medical Point Hospital, Gaziantep, Turkey, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Clinical and Applied Thrombosis/Hemostasis, adding:

”We are moving from lifelong intravenous infusions to single-dose gene therapies and seamless subcutaneous agents in hemophilia care.

But as the therapeutic landscape shifts, how prepared are developing economies to absorb the heavy budget impact of these high-value innovations?

Our latest comprehensive review, now published in Clinical and Applied Thrombosis/Hemostasis (SCIE, Impact Factor: 3.2, Q2 in Hematology), analyzes the expanding real-world experience, access barriers, and future opportunities in regions like Türkiye and beyond.

Read our full paper to explore the delicate balance between medical breakthroughs and healthcare sustainability.”

Title: The Dilemma of Providing Advanced Hemophilia Treatments in Developing Countries – For Whom, by Whom and Where?

Authors: Kaan Kavaklı, Canan Albayrak, Bulent Antmen, Selin Aytac, Can Balkan, Zuhre Kaya, Alphan Kupesiz, Vahap Okan, Mehmet Sonmez, Fahri Sahin, Ekrem Unal, Bulent Zulfikar

Ekrem Unal: Navigating the Budget Impact of Next-Generation Hemophilia Therapies in Turkey

Stay updated on all scientific advances with Hemostasis Today.